We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $156M
1-Year Est. Return 14.89%
This Fund
S&P 500
This Quarter Est. Return
+28.88%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.09%
AUM
$453M
AUM Growth
-$9.38M
Cap. Flow
-$94.9M
Cap. Flow %
-20.93%
Top 10 Hldgs %
21.21%
Holding
909
New
156
Increased
102
Reduced
243
Closed
406

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$44.3M
2
MSFT icon
Microsoft
MSFT
+$6.19M
3
ACN icon
Accenture
ACN
+$5.66M
4
BIIB icon
Biogen
BIIB
+$4.48M
5
UAL icon
United Airlines
UAL
+$3.29M

Sector Composition

Rank Sector Weight
1 Technology 21.04%
2 Miscellaneous 14.77%
3 Consumer Discretionary 12.19%
4 Healthcare 10.75%
5 Industrials 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HUM icon
626
Humana
HUM
$47.4B
-2,844
Closed -$893K
HURN icon
627
Huron Consulting
HURN
$2.47B
-5,200
Closed -$236K
PPLI
628
People Inc
PPLI
$2.88B
-13,989
Closed -$448K
ICLR icon
629
Icon
ICLR
$13.3B
-2,036
Closed -$277K
ICUI icon
630
ICU Medical
ICUI
$3.89B
-2,091
Closed -$422K
IIPR icon
631
Innovative Industrial Properties
IIPR
$1.55B
-5,400
Closed -$410K
IJH icon
632
iShares Core S&P Mid-Cap ETF
IJH
$122B
-22,000
Closed -$633K
IJJ icon
633
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.58B
-4,200
Closed -$230K
INCY icon
634
Incyte
INCY
$24.6B
-3,239
Closed -$237K
INMD icon
635
InMode
INMD
$857M
-40,200
Closed -$432K
INO icon
636
Inovio Pharmaceuticals
INO
$121M
-4,233
Closed -$378K
INSM icon
637
Insmed
INSM
$26B
-11,500
Closed -$184K
INSP icon
638
Inspire Medical Systems
INSP
$2.16B
-11,997
Closed -$723K
IONS icon
639
Ionis Pharmaceuticals
IONS
$7.8B
-5,300
Closed -$251K
IP icon
640
International Paper
IP
$17.9B
-12,672
Closed -$374K
IPG
641
DELISTED
Interpublic Group of Companies
IPG
-32,700
Closed -$529K
IQ icon
642
iQIYI
IQ
$975M
-28,021
Closed -$499K
IR icon
643
Ingersoll Rand
IR
$27.8B
-17,055
Closed -$423K
IRBT
644
DELISTED
iRobot
IRBT
-10,100
Closed -$413K
IRWD icon
645
Ironwood Pharmaceuticals
IRWD
$676M
-21,100
Closed -$213K
ITRI icon
646
Itron
ITRI
$4.03B
-8,200
Closed -$458K
ITUB icon
647
Itaú Unibanco
ITUB
$91.4B
-21,440
Closed -$70K
JBL icon
648
Jabil
JBL
$31.1B
-21,145
Closed -$520K
JBSS icon
649
John B. Sanfilippo & Son
JBSS
$795M
-4,294
Closed -$384K
JKS
650
JinkoSolar
JKS
$557M
-11,155
Closed -$166K

Similar funds

Bayesian Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Bayesian Capital Management held 909 positions worth $453M, down 2% from $463M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Bayesian Capital Management withdrew a net $94.9M in Q2 2020, closing 406 positions and reducing 243 holdings. Its most notable exit was ExxonMobil, an estimated $4.17M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.

Against the trend, Bayesian Capital Management opened a new position in State Street SPDR S&P 500 ETF Trust worth $46.7M.

  • Bayesian Capital Management's largest Q2 2020 buy was State Street SPDR S&P 500 ETF Trust: 151,500 shares worth $46.7M.
  • Bayesian Capital Management added most to Biogen in Q2 2020, an estimated $4.48M increase.
  • Bayesian Capital Management's biggest Q2 2020 reduction was Walgreens Boots Alliance, cutting an estimated $11.2M.
  • Bayesian Capital Management fully exited ExxonMobil in Q2 2020, selling an estimated $4.17M.
  • Bayesian Capital Management's ten largest holdings make up 21% of its $453M portfolio in Q2 2020.
  • Bayesian Capital Management opened 156 new positions and closed 406 in Q2 2020.
  • Bayesian Capital Management's portfolio value fell 2% quarter-over-quarter to $453M.

Based on Bayesian Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.